高盛：中国医疗保健_持续转向创新的药品政策；国家医保局将把商业保险创新药目录纳入国家医保药品目录

1 July 2025 | 10:57PM HKT China Healthcare: Drug policy pivoting towards innovation continues; NHSA to introduce commercial insurance novel drug list to NRDL Roll-out of long-anticipated policy framework: We note positively that China's domestic policy for drug innovation continues to evolve with new rules panning out - The National Healthcare Security Administration (NHSA) and the National Health Commission (NHC) jointly announced a new policy framework to further promote drug innovation in China, with new ...